Literature DB >> 8198034

In vivo mitral valve morphology and motion in mitral valve prolapse.

N J Weissman1, R Pini, M J Roman, R Kramer-Fox, H S Andersen, R B Devereux.   

Abstract

Mitral leaflet morphology in mitral valve prolapse (MVP) has been suggested to be prognostically important, but in vivo valvular morphology is incompletely described in patients with MVP or in normal subjects. Accordingly, the length of both mitral leaflets and their zone of apposition, the thickness of their rough and clear zones, diastolic and systolic mitral annular diameters, and indexes of abnormal leaflet motion were measured in the parasternal long-axis echocardiographic view in 100 patients with MVP and 100 age- and sex-matched normal subjects. In both groups posterior leaflet thickness was related to age, as were anterior leaflet thickness and posterior leaflet length in patients with MVP. Compared with normal subjects, MVP patients without mitral regurgitation had thickened leaflets, elongated anterior leaflets, and large annular diameters (p < 0.0001). Patients with severe regurgitation had thicker leaflets, longer posterior leaflet and annular dimensions, and more abnormal leaflet motion than MVP patients without regurgitation. Leaflet thicknesses of different zones were supranormal in 60% to 67% and in 49% to 59% of MVP patients with and without severe regurgitation, respectively. MVP patients with regurgitation also had higher prevalences of abnormal mitral annular diameter than those without regurgitation (67% vs 29%) and > 3 mm posterior leaflet billowing into the left atrium (60% vs 34%). Thus, mitral valve size and leaflet thickness are increased in MVP patients without as well as with clinically important mitral regurgitation. The usefulness of leaflet thickening as a marker of severe MVP is limited by its high prevalence in patients with clinically mild MVP.

Entities:  

Mesh:

Year:  1994        PMID: 8198034     DOI: 10.1016/0002-9149(94)90287-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4.

Authors:  Lisa A Freed; James S Acierno; Daisy Dai; Maire Leyne; Jane E Marshall; Francesca Nesta; Robert A Levine; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2003-04-21       Impact factor: 11.025

Review 2.  World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline.

Authors:  Bo Reményi; Nigel Wilson; Andrew Steer; Beatriz Ferreira; Joseph Kado; Krishna Kumar; John Lawrenson; Graeme Maguire; Eloi Marijon; Mariana Mirabel; Ana Olga Mocumbi; Cleonice Mota; John Paar; Anita Saxena; Janet Scheel; John Stirling; Satupaitea Viali; Vijayalakshmi I Balekundri; Gavin Wheaton; Liesl Zühlke; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-02-28       Impact factor: 32.419

3.  Increased frequency of mitral valve prolapse in patients with deviated nasal septum.

Authors:  Hasan Huseyin Arslan; Mustafa Aparci; Zekeriya Arslan; Cengiz Ozturk; Zafer Isilak; Sevket Balta; Turgay Celik; Atila Iyisoy
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-17       Impact factor: 2.503

4.  Mitral Leaflet Changes Following Myocardial Infarction: Clinical Evidence for Maladaptive Valvular Remodeling.

Authors:  Jonathan Beaudoin; Jacob P Dal-Bianco; Elena Aikawa; Joyce Bischoff; J Luis Guerrero; Suzanne Sullivan; Philipp Emanuel Bartko; Mark D Handschumacher; Dae-Hee Kim; Jill Wylie-Sears; Jacob Aaron; Robert A Levine
Journal:  Circ Cardiovasc Imaging       Date:  2017-11       Impact factor: 7.792

5.  Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28.

Authors:  F Kyndt; J J Schott; J N Trochu; F Baranger; O Herbert; V Scott; E Fressinaud; A David; J P Moisan; J B Bouhour; H Le Marec; B Bénichou
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

6.  Mitral valve enlargement in chronic aortic regurgitation as a compensatory mechanism to prevent functional mitral regurgitation in the dilated left ventricle.

Authors:  Jonathan Beaudoin; Mark D Handschumacher; Xin Zeng; Judy Hung; Eleanor L Morris; Robert A Levine; Ehud Schwammenthal
Journal:  J Am Coll Cardiol       Date:  2013-02-28       Impact factor: 24.094

7.  Relation of mitral valve morphology and motion to mitral regurgitation severity in patients with mitral valve prolapse.

Authors:  Mario Sénéchal; Nicolas Michaud; Jimmy Machaalany; Mathieu Bernier; Michelle Dubois; Julien Magne; Christian Couture; Patrick Mathieu; Olivier F Bertrand; Pierre Voisine
Journal:  Cardiovasc Ultrasound       Date:  2012-01-27       Impact factor: 2.062

8.  Plaque Vulnerability as Assessed by Radiofrequency Intravascular Ultrasound in Patients with Valvular Calcification.

Authors:  Nagendra Boopathy Senguttuvan; Sharath Kumar; Wang-Soo Lee; Sundeep Mishra; Jun Hwan Cho; Jee Eun Kwon; Seong Hyeop Hyeon; Yun Sang Jeong; Hoyoun Won; Seung Yong Shin; Kwang Je Lee; Tae Ho Kim; Chee Jeong Kim; Sang-Wook Kim
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

9.  Mitral valve prolapse syndrome and MASS phenotype: Stability of aortic dilatation but progression of mitral valve prolapse.

Authors:  Moritz Rippe; Julie De Backer; Kerstin Kutsche; Laura Muiño Mosquera; Helke Schüler; Meike Rybczynski; Alexander M Bernhardt; Britta Keyser; Mathias Hillebrand; Thomas S Mir; Jürgen Berger; Stefan Blankenberg; Dietmar Koschyk; Yskert von Kodolitsch
Journal:  Int J Cardiol Heart Vasc       Date:  2016-01-21

10.  Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I.

Authors:  O I I Soliman; R G M Timmermans; A Nemes; W B Vletter; J H P Wilson; F J ten Cate; M L Geleijnse
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.